Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Other Non-Current Assets (2023 - 2025)

Bioharvest Sciences has reported Other Non-Current Assets over the past 3 years, most recently at $433000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 16.71% year-over-year to $433000.0; the TTM value through Dec 2025 reached $433000.0, up 16.71%, while the annual FY2025 figure was $433000.0, 16.71% up from the prior year.
  • Other Non-Current Assets was $433000.0 for Q4 2025 at Bioharvest Sciences, up from $405000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $433000.0 in Q4 2025 and bottomed at $179000.0 in Q4 2023.
  • The 3-year median for Other Non-Current Assets is $371000.0 (2024), against an average of $364666.7.
  • Year-over-year, Other Non-Current Assets soared 107.26% in 2024 and then decreased 2.7% in 2025.
  • Over 3 years, Other Non-Current Assets stood at $179000.0 in 2023, then skyrocketed by 107.26% to $371000.0 in 2024, then grew by 16.71% to $433000.0 in 2025.
  • The last three reported values for Other Non-Current Assets were $433000.0 (Q4 2025), $405000.0 (Q3 2025), and $397000.0 (Q2 2025) per Business Quant data.